Safety and Effectiveness of Spiriva in COPD (Chronic Obstructive Pulmonary Disease) Patients Under the Real Condition of Usual Practice
Phase of Trial: Phase IV
Latest Information Update: 17 May 2012
At a glance
- Drugs Tiotropium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- Sponsors Boehringer Ingelheim
- 17 May 2012 Actual end date changed from Feb 2010 to Mar 2010 as reported by ClinicalTrials.gov.
- 17 May 2012 Actual patient number chnaged from (1054) to (2031) as reported by ClinicalTrials.gov.
- 16 Apr 2010 Actual patient number (1054) added as reported by ClinicalTrials.gov.